In addition, TRPA1 has been found to contribute to many preclinical models of inflammatory diseases such as allergic contact dermatitis [24], ovalbumin-induced allergic inflammation [36], carrageenan-induced acute inflammation [19], gout [20,21], osteoarthritis [22] and inflammatory bowel disease [37]. This evidence concerns the gene TRPA1 and gout.